Jun 14, 2021 6:00am EDT NeonMind to Present at H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference
May 26, 2021 6:00am EDT NeonMind Announces Creation of Medical Clinics Advisory Board to Guide Planning and Operation of Company-Branded Clinics Across Canada
Apr 22, 2021 6:00am EDT NeonMind Announces New Specialty Clinics Division to Deliver Innovative Mental Health Services, Appoints New VP, Corporate Development
Mar 30, 2021 6:00am EDT NeonMind CEO Robert Tessarolo to Speak at the Psychedelic, Therapeutics, & Drug Development Conference
Mar 23, 2021 2:00am EDT NeonMind CEO Provides Update on the Progress of its Psilocybin Drug Development Research Plan and Team
Mar 11, 2021 6:00am EST NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for Obesity
Mar 09, 2021 2:00am EST NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity